In this exclusive MedPage Today video, investigator Shahzad Raza, MD, of the Cleveland Clinic Cancer Institute, explains why ...

In May, the company announced the failure of the monoclonal antibody birtamimab to improve mortality in a phase 3 trial of ...

THIRUVANANTHAPURAM: The Association of Medical and Paediatric Oncologists of Kerala (AMPOK) announced a research grant of Rs ...

Harry Monroe has been an educator for 51 years. He spent 33 of those with Dallas ISD. Now, he's leaving for health reasons.

Diversified Trust Co decreased its position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) by 40.3% during the ...

New research shows that low-intensity repetitive transcranial magnetic stimulation (rTMS) can restore key synaptic structures in mouse models of Alzheimer’s disease.

Drugs that treat a similar plasma cell disease, multiple myeloma, can sometimes be effective in people with AL amyloidosis. By far, the most important of these drugs is daratumumab (Darzalex), a ...

Elsie soon learned the cause - cardiac amyloidosis. "We used to think of it more as a rare disease," says Dr. Carly Fabrizio of Temple Health. But Dr. Fabrizio says heart failure specialists like ...

Alzheimer's disease (AD) is a debilitating neurodegenerative condition that affects a significant proportion of older people ...

AS-Amyloidosis Consortium. Nitsche and colleagues looked at 226 patients (mean age 85 years; 80.4% male) with both moderate/severe AS and ATTR-CA who enrolled in the registry across 16 specialist ...

Scientists in Australia have discovered that a magnetic brain treatment already used for depression can boost the brain’s ...